Liquidia
Seth Hall is a Medical Science Liaison at Liquidia Corporation since December 2023, previously serving as Principal Clinical Science Liaison, Clinical Science Liaison, Senior Clinical Specialist, and Clinical Specialist at Mallinckrodt Pharmaceuticals from June 2017 to December 2023. Prior experience includes a role as Hospital Development Coordinator at Indiana Donor Network, focusing on critical care hospital liaison efforts, and various positions as a Travel Respiratory Care Practitioner at institutions such as Duke University Health System and Stanford Children's Health, specializing in pediatric and cardiac intensive care. Educational qualifications include a PhD in Health Sciences from Liberty University (2021-2024), an MBA in Healthcare Administration from the University of Southern Indiana (2018-2019), and a Bachelor's degree in Biology from West Virginia University.
This person is not in any teams
This person is not in any offices
Liquidia
Liquidia is a biopharmaceutical company focused on the development and commercialization of products that address unmet patient needs, with current focus directed towards the treatment of pulmonary arterial hypertension (PAH).